Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuromyelitis Optica Spectrum Disease (NMOSD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT04886492
What this trial is testing

CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
CorEvitas 800
Not applicableLooking for participantsNCT07377305
What this trial is testing

Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
NMO Spectrum Disorder
Tang-Du Hospital 12
Testing effectiveness (Phase 2)Looking for participantsNCT05549258
What this trial is testing

Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Amgen 15
Not applicableNot Yet RecruitingNCT07304960
What this trial is testing

Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder

Who this might be right for
MS (Multiple Sclerosis)NMO Spectrum Disorder (NMOSD)
Assiut University 100
Early research (Phase 1)Study completedNCT04227470
What this trial is testing

HBM9161 in NMOSD Patients

Who this might be right for
NMO Spectrum Disorder
Harbour BioMed (Guangzhou) Co. Ltd. 9
Early research (Phase 1)Looking for participantsNCT07085676
What this trial is testing

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)Rheumatoid Arthritis (RA)+6 more
Polina Stepensky 120
Post-approval studies (Phase 4)Active Not RecruitingNCT06180278
What this trial is testing

Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Amgen 32
Not applicableNot Yet RecruitingNCT07159893
What this trial is testing

Inectolizumab With Steroid Optimization in Newly Treated NMOSD

Who this might be right for
Neuromyelitis OpticaAutoimmune DiseasesDemyelinating Autoimmune Diseases, CNS
First Affiliated Hospital of Wenzhou Medical University 25
Not applicableLooking for participantsNCT06312644
What this trial is testing

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Who this might be right for
Ultomiris-exposed Pregnant/ PostpartumPregnancyParoxysmal Nocturnal Hemoglobinuria (PNH)+3 more
Alexion Pharmaceuticals, Inc. 75
Testing effectiveness (Phase 2)Looking for participantsNCT06697535
What this trial is testing

Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Guangzhou JOYO Pharma Co., Ltd 35
Very early researchNot Yet RecruitingNCT07592754
What this trial is testing

The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.

Who this might be right for
Neuromyelitis Optica Spectrum Disease (NMOSD)
Chinese PLA General Hospital 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07685678
What this trial is testing

Study on Efficacy Evaluation of Ripertamab in the Treatment of Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disease (NMOSD)Ripertamab
Zhongming Qiu 20
Testing effectiveness (Phase 2)WithdrawnNCT06673394
What this trial is testing

Eculizumab For Acute Attack of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital
Not applicableNot Yet RecruitingNCT07266051
What this trial is testing

Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD)

Who this might be right for
NMOSD
Xiamen Hospital of Traditional Chinese Medicine 4,000
Large-scale testing (Phase 3)Active Not RecruitingNCT06724809
What this trial is testing

Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD

Who this might be right for
NMOSDNeuromyelitis Optica Spectrum Disorders
Alexion Pharmaceuticals, Inc. 21
Not applicableLooking for participantsNCT06780709
What this trial is testing

Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Icahn School of Medicine at Mount Sinai 20
Testing effectiveness (Phase 2)Ended earlyNCT05356858
What this trial is testing

An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients

Who this might be right for
Neuromyelitis Optica
Xuanwu Hospital, Beijing 6
Large-scale testing (Phase 3)Ended earlyNCT04155424
What this trial is testing

The Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 5
Not applicableWithdrawnNCT04131673
What this trial is testing

MS and NMOSD in African-Americans

Who this might be right for
Multiple SclerosisNeuromyelitis Optica
Jagannadha R Avasarala
Testing effectiveness (Phase 2)Study completedNCT05551598
What this trial is testing

Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 46
Next Page